EC AUTOBIO 1 a Series of CGF2021 LLC has filed a new offering with the SEC, raising a total of $46,000. This funding is intended to cover the company's organizational and operating expenses, marking a significant step for the firm as it establishes its footing in the private equity landscape.
The filing, dated October 22, 2026, indicates that the company is taking advantage of Rule 506(b), which provides a safe harbor for private offerings. This regulatory framework is designed to facilitate capital raising while ensuring compliance with federal securities laws.
Background
EC AUTOBIO 1 a Series of CGF2021 LLC is a limited liability company incorporated in Delaware. The firm operates as a pooled investment fund, specifically a private equity fund. As of the latest filing, there are no publicly traded tickers or exchanges associated with the company.
What the Filing Says
The SEC filing reveals that the total offering amount is $46,000, with the entire amount already sold. The filing states, "This amount represents a cost to cover fund organizational and operating expenses." The minimum investment accepted was set at zero, making it accessible for various investors.
Impact
The funding raised through this offering may affect the firm's operational capabilities and its future investment strategies. With three investors already on board, the company is poised to leverage this capital for growth and development within the private equity market.
What's Next
The filing does not say what happens next.